مباشر
Novo NordiskNovo Nordisk’s CagriSema Breakthrough Expands Growth Story Beyond Diabetes and Obesity - simplywall.stMKS NewportCenters Receive Awards for Nanoscale Research | light speed | Feb 2002 - Photonics SpectraEurofinsEurofins Scientific SE Stock (FR0014000MR3): stock in focus after quiet trading week - AD HOC NEWSCellMechanism of lipid transfer by bridge-like protein VPS13A and the scramblase XKCellGregory J. Hannon (1964–2026)10x Genomics NewsCanaccord reiterates Buy on 10X Genomics stock after acquisition By Investing.com - Investing.com NigeriaFierceBiotechLilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’Eli LillyLilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting - investor.lilly.comEli LillyLilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting - PR NewswireEli LillyLilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate’ - Fierce BiotechEli LillyAbridge partners with Eli Lilly, Nvidia as AI scribe eyes expansion - Healthcare DiveEndpoints NewsBiopharma’s 2025 industry pay report; Parabilis sets industry record IPO; and more
هذا المقال غير متوفر في الأرشيف.